|
APC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.9418999999995E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.90780000000257E-05 |
| Normal-vs-Stage2 |
7.922000E-03 |
| Normal-vs-Stage3 |
2.300200E-02 |
| Normal-vs-Stage4 |
8.583700E-02 |
| Stage1-vs-Stage2 |
9.906600E-01 |
| Stage1-vs-Stage3 |
6.184200E-01 |
| Stage1-vs-Stage4 |
9.914000E-01 |
| Stage2-vs-Stage3 |
6.531200E-01 |
| Stage2-vs-Stage4 |
9.981000E-01 |
| Stage3-vs-Stage4 |
7.302800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.92979999985776E-07 |
| Normal-vs-AfricanAmerican |
7.544200E-02 |
| Normal-vs-Asian |
4.079800E-01 |
| Caucasian-vs-AfricanAmerican |
2.017800E-01 |
| Caucasian-vs-Asian |
5.077200E-01 |
| AfricanAmerican-vs-Asian |
9.953800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.13729999862144E-08 |
| Normal-vs-Female |
7.323200E-01 |
| Male-vs-Female |
6.158100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.459600E-02 |
| Normal-vs-Extreme_Weight |
5.99460003858354E-09 |
| Normal-vs-Obese |
8.575600E-04 |
| Normal-vs-Extreme_Obese |
8.353100E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.495770E-01 |
| Normal_Weight-vs-Obese |
8.058400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.015000E-01 |
| Extreme_Weight-vs-Obese |
3.785900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.786200E-01 |
| Obese-vs-Extreme_Obese |
5.161600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.212380E-02 |
| Normal-vs-Age(41-60Yrs) |
2.994300E-02 |
| Normal-vs-Age(61-80Yrs) |
8.58390003521947E-09 |
| Normal-vs-Age(81-100Yrs) |
1.056920E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.014800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.157200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.158000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.103500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.526220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.842600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.46370000459117E-08 |
| Normal-VS-Type2 PRCC |
7.512400E-02 |
| Normal-VS-KIRP CIMP |
1.82689999994601E-06 |
| Normal-VS-Unclassified PRCC |
4.414200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.853500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.389600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.511600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.944400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.881600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.161000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.70820000000061E-05 |
| Normal-vs-N1 |
1.179590E-01 |
| Normal-vs-N2 |
2.796100E-03 |
| N0-vs-N1 |
2.317000E-01 |
| N0-vs-N2 |
6.252800E-01 |
| N1-vs-N2 |
3.505000E-01 |
|
|
